Washington State COMMUNICABLE DISEASE REPORT 2011 For additional copies of this document or to obtain this document in an alternative format please contact: Washington State Department of Health Office of Communicable Disease Epidemiology 1610 NE 150th Street Shoreline, WA 98155 206.418.5500 or 1.877.539.4344 DOH 420-004 WASHINGTON STATE DEPARTMENT OF HEALTH Epidemiology, Health Statistics and Public Health Laboratories Communicable Disease Epidemiology 1610 NE 150th Street Shoreline, WA 98155 206-418-5500 or 1-877-539-4344 COMMUNICABLE DISEASE REPORT 2011 CONTRIBUTORS COMMUNICABLE DISEASE EPIDEMIOLOGY Mary Chadden Natasha Close, MPH Marisa D’Angeli, MD, MPH Chas DeBolt, RN, MPH Marcia Goldoft, MD, MPH, MS Kathy Lofy, MD Kathryn MacDonald, PhD Nicola Marsden-Haug, MPH Jasmine Matheson, MPH Kathleen Stigi, MPH Tracy Sandifer, MPH Azadeh Tasslimi, MPH Doreen Terao Sherryl Terletter Wayne Turnberg, PhD, MSPH DISEASE CONTROL AND HEALTH STATISTICS Maria Courogen, MPH Jennifer Reuer, MPH Shawn McBrien, MPH Tom Jaenicke, MPH, MBA, MES Julieann Simon, MSPH PREVENTION AND COMMUNITY HEALTH Shana Johnny, RN, MN i Mary Selecky Secretary of Health Maxine Hayes, MD, MPH Health Officer Jennifer Tebaldi, MBA, RS Assistant Secretary Disease Control and Health Statistics Wayne Turnberg, PhD, MSPH Director for the Office of Communicable Disease Epidemiology Maria Courogen, MPH Director for the Office of Infectious Disease Vacant State Epidemiologist for Communicable Disease Romesh Gautom, PhD Director, Public Health Laboratories Juliet VanEenwyk, PhD, MS State Epidemiologist for Non-Infectious Disease This report represents Washington State communicable disease surveillance: the ongoing collection, analysis and dissemination of morbidity and mortality data to prevent and control communicable disease. In addition to the contributors listed on the previous page, we would like to recognize the staff of the Washington State Public Health Laboratories, the staff of Washington’s local health jurisdictions who contribute to surveillance, investigation, and prevention of communicable diseases in our state, and the thousands of people in clinics, hospitals and clinical laboratories throughout Washington whose disease reports constitute the basis for this document. Revised January 2013 ii Table of Contents Executive Summary – 2011 .................................................................................................................................... v Technical Notes ...................................................................................................................................................... v Reporting a Notifiable Condition........................................................................................................................... vi Arboviral Disease.................................................................................................................................................... 3 West Nile Virus (WNV) Disease ......................................................................................................................... 3 Yellow Fever ....................................................................................................................................................... 4 Botulism .................................................................................................................................................................. 4 Brucellosis............................................................................................................................................................... 5 Campylobacteriosis ................................................................................................................................................. 5 Chlamydia Infection................................................................................................................................................ 6 Cholera .................................................................................................................................................................... 6 Cryptosporidiosis .................................................................................................................................................... 6 Cyclosporiasis ......................................................................................................................................................... 7 Diphtheria ............................................................................................................................................................... 7 Giardiasis ................................................................................................................................................................ 8 Gonorrhea ............................................................................................................................................................... 8 Haemophilus influenzae (Invasive Disease, Under Age 5 Years) .......................................................................... 8 Hantavirus Pulmonary Syndrome (HPS) ................................................................................................................ 9 Hepatitis A .............................................................................................................................................................. 9 Hepatitis B ............................................................................................................................................................ 10 Hepatitis C ............................................................................................................................................................ 10 Hepatitis D or E .................................................................................................................................................... 11 Herpes Simplex, Genital and Neonatal ................................................................................................................. 11 HIV/AIDS ............................................................................................................................................................. 12 Legionellosis ......................................................................................................................................................... 12 Leptospirosis ......................................................................................................................................................... 13 Listeriosis .............................................................................................................................................................. 13 Lyme Disease ........................................................................................................................................................ 14 Malaria .................................................................................................................................................................. 14 Measles ................................................................................................................................................................. 14 Meningococcal Disease (Invasive) ....................................................................................................................... 15 Mumps .................................................................................................................................................................. 16 Pertussis ................................................................................................................................................................ 16 Plague .................................................................................................................................................................... 17 Polio ...................................................................................................................................................................... 17 Psittacosis .............................................................................................................................................................. 18 Q Fever.................................................................................................................................................................. 18 Rabies (Human) .................................................................................................................................................... 19 Rabies, Suspected Human Exposure..................................................................................................................... 19 Rare Diseases of Public Health Significance ........................................................................................................ 23 Melioidosis ........................................................................................................................................................ 23 Coccidioidomycosis (Valley Fever) .................................................................................................................. 23 Creutzfeldt-Jakob Disease (CJD) ...................................................................................................................... 23 Cryptococcosis..................................................................................................................................................